Polypharmacy in the Elderly-When Good Drugs Lead to Bad Outcomes: A Teachable Moment. [electronic resource]
- JAMA internal medicine 06 2017
- 871 p. digital
Publication Type: Case Reports; Journal Article
2168-6114
10.1001/jamainternmed.2017.0911 doi
Aged, 80 and over Anti-Arrhythmia Agents--therapeutic use Antihypertensive Agents--poisoning Atorvastatin--therapeutic use Atrial Fibrillation--complications Bone Density Conservation Agents--therapeutic use Deprescriptions Digoxin--therapeutic use Diltiazem--therapeutic use Diuretics--therapeutic use Drug Overdose Factor Xa Inhibitors--therapeutic use Female Furosemide--therapeutic use Heart Failure--complications Histamine H1 Antagonists, Non-Sedating--therapeutic use Histamine H2 Antagonists--therapeutic use Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use Ibandronic Acid--therapeutic use Lisinopril--therapeutic use Loratadine--therapeutic use Metoprolol--poisoning Polypharmacy Pyrazoles--therapeutic use Pyridones--therapeutic use Ranitidine--therapeutic use Syncope--chemically induced